Gilead Sciences, Inc. (GILD)
121.18
-0.04
(-0.03%)
USD |
NASDAQ |
Dec 08, 16:00
120.32
-0.86
(-0.71%)
After-Hours: 19:48
Gilead Sciences Shareholders Equity (Quarterly): 21.54B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amgen, Inc. | 9.619B |
| Johnson & Johnson | 79.28B |
| Eli Lilly & Co. | 23.79B |
| Merck & Co., Inc. | 51.85B |
| Pfizer Inc. | 92.80B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 58.53B |
| Total Liabilities (Quarterly) | 37.08B |
| Debt to Equity Ratio | 1.158 |
| Current Ratio | 1.453 |
| Net Debt Paydown Yield | -0.23% |